img

Global Lanreotide Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lanreotide Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
Lanreotide Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lanreotide Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lanreotide Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lanreotide Injection key manufacturers include Ipsen and Cipla etc. Ipsen, Cipla, are top 3 players and held % sales share in total in 2022.
Lanreotide Injection can be divided into Sustained Release Formulation and Long-acting Formula, etc. Sustained Release Formulation is the mainstream product in the market, accounting for % sales share globally in 2022.
Lanreotide Injection is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Lanreotide Injection industry development. In 2022, global % sales of Lanreotide Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lanreotide Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ipsen
Cipla
Segment by Type
Sustained Release Formulation
Long-acting Formula

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lanreotide Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lanreotide Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lanreotide Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Lanreotide Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lanreotide Injection introduction, etc. Lanreotide Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Lanreotide Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Lanreotide Injection Market Overview
1.1 Lanreotide Injection Product Overview
1.2 Lanreotide Injection Market Segment by Type
1.2.1 Sustained Release Formulation
1.2.2 Long-acting Formula
1.3 Global Lanreotide Injection Market Size by Type
1.3.1 Global Lanreotide Injection Market Size Overview by Type (2024-2034)
1.3.2 Global Lanreotide Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global Lanreotide Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lanreotide Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe Lanreotide Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Lanreotide Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Lanreotide Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Lanreotide Injection Sales Breakdown by Type (2024-2024)
2 Global Lanreotide Injection Market Competition by Company
2.1 Global Top Players by Lanreotide Injection Sales (2024-2024)
2.2 Global Top Players by Lanreotide Injection Revenue (2024-2024)
2.3 Global Top Players by Lanreotide Injection Price (2024-2024)
2.4 Global Top Manufacturers Lanreotide Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lanreotide Injection Market Competitive Situation and Trends
2.5.1 Lanreotide Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Lanreotide Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lanreotide Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Lanreotide Injection Market
2.8 Key Manufacturers Lanreotide Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lanreotide Injection Status and Outlook by Region
3.1 Global Lanreotide Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Lanreotide Injection Historic Market Size by Region
3.2.1 Global Lanreotide Injection Sales in Volume by Region (2024-2024)
3.2.2 Global Lanreotide Injection Sales in Value by Region (2024-2024)
3.2.3 Global Lanreotide Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Lanreotide Injection Forecasted Market Size by Region
3.3.1 Global Lanreotide Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Lanreotide Injection Sales in Value by Region (2024-2034)
3.3.3 Global Lanreotide Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Lanreotide Injection by Application
4.1 Lanreotide Injection Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Lanreotide Injection Market Size by Application
4.2.1 Global Lanreotide Injection Market Size Overview by Application (2024-2034)
4.2.2 Global Lanreotide Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global Lanreotide Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lanreotide Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe Lanreotide Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Lanreotide Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Lanreotide Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Lanreotide Injection Sales Breakdown by Application (2024-2024)
5 North America Lanreotide Injection by Country
5.1 North America Lanreotide Injection Historic Market Size by Country
5.1.1 North America Lanreotide Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Lanreotide Injection Sales in Volume by Country (2024-2024)
5.1.3 North America Lanreotide Injection Sales in Value by Country (2024-2024)
5.2 North America Lanreotide Injection Forecasted Market Size by Country
5.2.1 North America Lanreotide Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Lanreotide Injection Sales in Value by Country (2024-2034)
6 Europe Lanreotide Injection by Country
6.1 Europe Lanreotide Injection Historic Market Size by Country
6.1.1 Europe Lanreotide Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Lanreotide Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe Lanreotide Injection Sales in Value by Country (2024-2024)
6.2 Europe Lanreotide Injection Forecasted Market Size by Country
6.2.1 Europe Lanreotide Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Lanreotide Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Lanreotide Injection by Region
7.1 Asia-Pacific Lanreotide Injection Historic Market Size by Region
7.1.1 Asia-Pacific Lanreotide Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Lanreotide Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Lanreotide Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Lanreotide Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Lanreotide Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Lanreotide Injection Sales in Value by Region (2024-2034)
8 Latin America Lanreotide Injection by Country
8.1 Latin America Lanreotide Injection Historic Market Size by Country
8.1.1 Latin America Lanreotide Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Lanreotide Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America Lanreotide Injection Sales in Value by Country (2024-2024)
8.2 Latin America Lanreotide Injection Forecasted Market Size by Country
8.2.1 Latin America Lanreotide Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Lanreotide Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Lanreotide Injection by Country
9.1 Middle East and Africa Lanreotide Injection Historic Market Size by Country
9.1.1 Middle East and Africa Lanreotide Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Lanreotide Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Lanreotide Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Lanreotide Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Lanreotide Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Lanreotide Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Ipsen
10.1.1 Ipsen Company Information
10.1.2 Ipsen Introduction and Business Overview
10.1.3 Ipsen Lanreotide Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Ipsen Lanreotide Injection Products Offered
10.1.5 Ipsen Recent Development
10.2 Cipla
10.2.1 Cipla Company Information
10.2.2 Cipla Introduction and Business Overview
10.2.3 Cipla Lanreotide Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Cipla Lanreotide Injection Products Offered
10.2.5 Cipla Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lanreotide Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lanreotide Injection Industrial Chain Analysis
11.4 Lanreotide Injection Market Dynamics
11.4.1 Lanreotide Injection Industry Trends
11.4.2 Lanreotide Injection Market Drivers
11.4.3 Lanreotide Injection Market Challenges
11.4.4 Lanreotide Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lanreotide Injection Distributors
12.3 Lanreotide Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Sustained Release Formulation
Table 2. Major Company of Long-acting Formula
Table 3. Global Lanreotide Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Lanreotide Injection Sales by Type (2024-2024) & (K Units)
Table 5. Global Lanreotide Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Lanreotide Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global Lanreotide Injection Market Share in Value by Type (2024-2024)
Table 8. Global Lanreotide Injection Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Lanreotide Injection Sales by Type (2024-2034) & (K Units)
Table 10. Global Lanreotide Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Lanreotide Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Lanreotide Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Lanreotide Injection Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Lanreotide Injection Sales by Type (2024-2024) & (K Units)
Table 15. North America Lanreotide Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Lanreotide Injection Sales (K Units) by Type (2024-2024)
Table 17. Europe Lanreotide Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Lanreotide Injection Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Lanreotide Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Lanreotide Injection Sales (K Units) by Type (2024-2024)
Table 21. Latin America Lanreotide Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Lanreotide Injection Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Lanreotide Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Lanreotide Injection Sales by Company (2024-2024) & (K Units)
Table 25. Global Lanreotide Injection Sales Share by Company (2024-2024)
Table 26. Global Lanreotide Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Lanreotide Injection Revenue Share by Company (2024-2024)
Table 28. Global Market Lanreotide Injection Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Lanreotide Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Lanreotide Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lanreotide Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Lanreotide Injection Market
Table 33. Key Manufacturers Lanreotide Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Lanreotide Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Lanreotide Injection Sales by Region (2024-2024) & (K Units)
Table 37. Global Lanreotide Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Lanreotide Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Lanreotide Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global Lanreotide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Lanreotide Injection Sales by Region (2024-2034) & (K Units)
Table 42. Global Lanreotide Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Lanreotide Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Lanreotide Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Lanreotide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Lanreotide Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Lanreotide Injection Sales by Application (2024-2024) & (K Units)
Table 48. Global Lanreotide Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Lanreotide Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Lanreotide Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global Lanreotide Injection Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Lanreotide Injection Sales by Application (2024-2034) & (K Units)
Table 53. Global Lanreotide Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Lanreotide Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Lanreotide Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Lanreotide Injection Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Lanreotide Injection Sales by Application (2024-2024) (K Units)
Table 58. North America Lanreotide Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Lanreotide Injection Sales by Application (2024-2024) (K Units)
Table 60. Europe Lanreotide Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Lanreotide Injection Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Lanreotide Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Lanreotide Injection Sales by Application (2024-2024) (K Units)
Table 64. Latin America Lanreotide Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Lanreotide Injection Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Lanreotide Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Lanreotide Injection Sales by Country (2024-2024) & (K Units)
Table 68. North America Lanreotide Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Lanreotide Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Lanreotide Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America Lanreotide Injection Sales by Country (2024-2034) & (K Units)
Table 72. North America Lanreotide Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Lanreotide Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Lanreotide Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Lanreotide Injection Sales by Country (2024-2024) & (K Units)
Table 76. Europe Lanreotide Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Lanreotide Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Lanreotide Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Lanreotide Injection Sales by Country (2024-2034) & (K Units)
Table 80. Europe Lanreotide Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Lanreotide Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Lanreotide Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Lanreotide Injection Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Lanreotide Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Lanreotide Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Lanreotide Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Lanreotide Injection Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Lanreotide Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Lanreotide Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Lanreotide Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Lanreotide Injection Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Lanreotide Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Lanreotide Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Lanreotide Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Lanreotide Injection Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Lanreotide Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Lanreotide Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Lanreotide Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Lanreotide Injection Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Lanreotide Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Lanreotide Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Lanreotide Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Lanreotide Injection Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Lanreotide Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Lanreotide Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Lanreotide Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Ipsen Company Information
Table 108. Ipsen Introduction and Business Overview
Table 109. Ipsen Lanreotide Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Ipsen Lanreotide Injection Product
Table 111. Ipsen Recent Development
Table 112. Cipla Company Information
Table 113. Cipla Introduction and Business Overview
Table 114. Cipla Lanreotide Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Cipla Lanreotide Injection Product
Table 116. Cipla Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Lanreotide Injection Market Trends
Table 120. Lanreotide Injection Market Drivers
Table 121. Lanreotide Injection Market Challenges
Table 122. Lanreotide Injection Market Restraints
Table 123. Lanreotide Injection Distributors List
Table 124. Lanreotide Injection Downstream Customers
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Lanreotide Injection Product Picture
Figure 2. Global Lanreotide Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Lanreotide Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Lanreotide Injection Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Sustained Release Formulation
Figure 6. Global Sustained Release Formulation Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Long-acting Formula
Figure 8. Global Long-acting Formula Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Lanreotide Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Lanreotide Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Lanreotide Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Lanreotide Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Lanreotide Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Lanreotide Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Lanreotide Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Lanreotide Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Lanreotide Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Lanreotide Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Lanreotide Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Lanreotide Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Lanreotide Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Lanreotide Injection Revenue in 2022
Figure 23. Lanreotide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Lanreotide Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Lanreotide Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Lanreotide Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Lanreotide Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Lanreotide Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Lanreotide Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Lanreotide Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Lanreotide Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Lanreotide Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Lanreotide Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Lanreotide Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Lanreotide Injection Manufacturing Cost Structure
Figure 43. Lanreotide Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed